Introduction

Introduction 4 (7) (8) (9) . OspA is furthermore used as a vaccine against LD, and first clinical trials show promising efficiacies (10, 11) .
Since culture of B. burgdorferi is difficult, diagnosis of LD, in addition to clinical aspects, is based on the presence of antibodies in patient´s serum against a series of B. burgdorferi outer membrane proteins. LD diagnosis requires positive ELISA testing, confirmed by Western blotting (12). The reaction pattern against different proteins yields information on duration and course of the disease since antibodies appear at different time points. Immunity against Borrelia flagellin (p41) appears early during disease and is often accompanied by antibodies recognizing OspC (13, 14) . Later on, a more complex pattern can be observed including antibodies against p100 and p17 (13-15). However, lipoproteins substantially vary among different B. burgdorferi subspecies, thus complicating the development of a diagnostic procedure suitable for all affected areas (16) (17) (18) . A recent study reported MGalD in B.
burgdorferi, and investigation of sera derived from patients suffering from LD revealed that this glycolipid may also be immunogenic (19) indicating that glycolipids in common may attribute to adaptive immunity against B. burgdorferi.
The aim of this study was to elucidate the nature of complex glycolipids in B. burgdorferi sensu stricto. We found that this strain, in addition to MGalD, also exhibits cholesterylglycosides cholesteryl 6-O-acyl-β-D-galactopyranoside (ACG) and cholesteryl β-Dgalactopyranoside (CG), both containing galactose instead of glucose as reported in B. hermsi min. while shaking and subsequently spun at 5.000 x g at 4 °C for 60 min. The resulting butanol-phase was saved and the water-phase and interphase were re-extracted under the same conditions. Both, butanol-and water-phase were excessively dialyzed against distilled water at 4 °C for 3 d employing tubes with a molecular weight cut-off of 10-14 kDa (Roth, Braunschweig, Germany), followed by lyophilization. The butanol-phase yielded 187.4 mg, and 98 mg were subjected to Bligh/Dyer extraction (21) , yielding 89 mg of organic (representing 87 % of the introduced butanol-phase). The water phase of the butanol/waterstep was saved for other studies. 20 mL of BSK-H medium were also lyophilized and subjected to combined butanol-Bligh/Dyer extraction as described above as negative control.
Analytical Thin Layer Chromatography (TLC) and Preparative Layer Chromatography (PLC)
Analytical TLC was performed employing aluminium silica gel sheets (0.2 mm, Kieselgel 60 F 254 , Merck, Darmstadt, Germany). 10 to 30 µg of the samples were loaded, gels were run in 
Gas-liquid Chromatography (GLC) and Combined Gas-liquid Chromatography/Mass
Spectroscopy (GLC-MS)
Compositional analysis employing GLC-MS was performed with 200 µg of each sample after methanolysis (1.5 mL 2 M HCl/MeOH), 85 °C, 1 h) in sealed ampoules. The samples were subsequently dried and peracetylated with 1 mL pyridine/acetanhydride (2:1 v/v, 80 °C, 1 h), concentrated and analyzed. GLC-MS was performed employing a HP-5MS column (30 m, Hewlett Packard, Palo Alto, USA) with a temperature gradient from 150 °C (3 min) to 320 °C at 5 °C/min. EI and CI-mass spectra were recorded as described (23, 24) .
Matrix-assisted Laser Desorption/Ionization Time of Flight (MALDI-TOF) Mass Spectrometry
As indicated, fractions were subjected to MALDI-TOF-MS performed with a Bruker-Reflex 
Nuclear Magnetic Resonance (NMR) Spectroscopy
For NMR analysis fractions were recorded on 0.5 mL CHCl 3 
Immunoblotting of Glycolipids
Polyacrylamide stacking gels (5%) and separating gels (16%) were cast with sodium dodecyl- 
Results
Lipid Composition of B. burgdorferi B31
The combined butanol/water-Bligh/Dyer-extraction procedure yielded a mixture of different polar lipids within the final organic phase, comprising 1.67 % of total wet weight, thus being in line with previous reports (19) . Employing TLC we were able to distinguish 6 fractions ( Fig. 1 ). In order to determine which fractions were derived from the BSK-H culture medium, TLC patterns of Borrelia extracts were compared with extracts derived from BSK-H alone, revealing that fractions F1a and b originated from culture medium (data not shown).
Therefore, we focused on the remaining lipids within fraction F2 (19 %), F3 (7 %), F4 (2.2 %) and F5 (22.5 %). Upon analytical TLC F5 co-migrated with and stained identical as compared to phosphatidylcholine which was previously described to be present in B.
burgdorferi (5, 19) . This fraction was analyzed by NMR in DMSO-d 6 which gave excellent spectral resolution and F5 showed identical NMR spectra as compared with commercial phosphatidylcholine (data not shown).
Identification of mono-α-D-galactosyl-diacylglycerol (MGalD)
GLC-MS analysis of fraction F3 revealed the presence of one hexose, one glycerol and several fatty acids, 
Lack of Induction of Proinflammatory Responses by Borrelia Glycolipids
A wide range of amphiphilic compounds derived from bacteria has been described to induce pro-inflammatory responses in mononuclear cells via a receptor complex involving Toll-like receptor 2 and CD14 (7, 8, 30, 31 (Fig. 4A) . In order to verify whether contaminating compounds were responsible for this activation, de-O-acetylation of F2 (ACG) was performed in order to obtain F2-OH (de-O-acylated ACG). This de-O-acylation quantitatively transferred F2 to F2-OH which, by analytical TLC, MALDI and NMR analysis, was found to be structurally identical to F4 (CG, data not shown). However, this preparation was not stimulatory active ( Fig. 4B) , indicating that some other yet undefined compounds were responsible for the effects observed with prepared CG.
Recognition of Borrelia Glycolipids by Antibodies Present in LD-Sera
Since previous studies suggested that MGalD may be immunogenic (19) , sera derived from patients suffering from LD were included in our studies in order to analyze them for the presence of antibodies against the purified glycolipids. In a first approach, we tested a single serum derived from a patient with clinical symptoms of Lyme arthritis and an IgG-pattern resembling a late stage immune response. We observed a strong reaction with Borrelia sonicate as well as with ACG, while CG and MGalD were non-reactive (Fig. 5A) . Serum derived from a patient tested negative for LD did not interact with any of the compounds tested (Fig. 5B) . In order to confer this pattern on a larger group of samples, we screened 12 patients with clinical and serological signs of LD employing dot blots. We examined 8 sera exhibiting a late stage of immune response with strong p17 and p100 bands, and the majority (n=7) of these sera were positive for ACG (Fig. 6) . A weak reaction with MGalD was observed only once (la2), and none of the sera showed any interaction with CG, the non- burgdorferi sensu stricto, B. garinii and B. afzelii), each displaying antigenic variations. Thus, development of an optimal procedure for laboratory testing employing proteinaceous antigens is quite complicated, and no consensus has been found yet (2, 4, 35) . In this study, we found that ACG present in B. burgdorferi interacts with sera derived from LD-patients, indicating that this compound acts as an antigen. We found a recognition of ACG by early as well as by late stage sera, indicating that antibodies against this compound may appear early and persist over a long period during disease. Interaction was found to be specific since sera derived from patients suffering from T. pallidum infection were not reactive, and no interaction was observed with healthy controls.
Since its non-acylated counterpart, CG, did not display any interaction with the sera tested, we postulate that galactose substituted with an unsaturated fatty acid at position 6 acts as an antigenic domain. It is tempting to speculate that B. garinii and B. afzelii also display Gels were blotted on membranes which were subsequently blocked and incubated with serum derived from a patient suffering from LD (A) as well as a healthy control (B, both diluted 1.000 fold). Antibodies against sonicates and purified glycolipids were detected by incubating the membrane with anti human IgG. Bands were visualized employing an ECL system. IgG. Bands were visualized employing an ECL system. Sera derived from LD-patients were evaluated twice. 
